The Challenge of Communicating Intent of Sedation in Advanced Illness

Journal of Palliative Care

Volumn 19, Issue 3, 2003, Pages 217-219

  Barreth, Angela ^a   Fainsinger, Robin ^a   Oneschuk, Doreen ^a   Pritchard, Zinia ^a  

^a GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HALOPERIDOL; LEVOMEPROMAZINE; MIDAZOLAM; OPIATE; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PAIN; CASE REPORT; CLERGY; CLINICAL FEATURE; CONSULTATION; DEATH; DELIRIUM; DISEASE COURSE; DYSPNEA; FAMILY; FEMALE; HUMAN; HYPOXEMIA; MEDICAL DECISION MAKING; METASTASIS; PALLIATIVE THERAPY; PATIENT SATISFACTION; PHYSICIAN; RELIGION; SEDATION; THORACOCENTESIS; UNCONSCIOUSNESS;

EID: 0242382786     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585970301900313     Document Type: Article

References (17)

1. Chater S, Raymond V, Paterson J, Jarvis V. Sedation for intractable distress in the dying: a survey of experts. Palliat Med 1998; 12: 225-269.
2. Cherny NI. Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage 1998; 16(6): 404-406.
3. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 2002; 24: 447-453.
4. Quill TE, Dresser R, Brock D. The role of double effect - a critique of its role in end-of-life decision making. N Engl J Med 1997; 337: 1768-1771.
5. Council on Ethical and Judicial Affairs, American Medical Association. Decisions near the end-of-life. JAMA 1992; 276: 2229-2233.
6. Smith GP. Terminal sedation as palliative care: revalidating a right to a good death. Camb Q Healthc Ethics 1998; 7: 382-387.
7. Ellis M, Vinson D, Ewigman B. Addressing spiritual concerns of patients: family physicians' attitudes and practices. J Fam Pract 1999; 48: 105-109.
8. Sloan RP, Bagiella E, Powell T. Religion, spirituality, and medicine. Lancet 1999; 353: 664-667.
9. Cohen CB, Wheeler SE, Scott DA. Walking a fine line: physician inquiries into patients' religious and spiritual beliefs. Hastings Cent Rep 2001; 31: 29-39.
10. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991; 7(1): 5-11.
11. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998; 16(3): 145-152.
12. Fainsinger RL. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000; 16(2): 5-10.
13. Ventafridda V, Ripamonti C, De Conno F. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990; 6(3): 7-11.
14. Burke AL, Diamone PL, Hulbert J, Yeatman, Farr EA. Terminal restlessness: its management and the role of midazolam. Med J Aust 1991; 155: 485-487.
15. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996; 12: 32-38.
16. Stone P, Phillips C, Spruit O, Waight C. A comparison of the use of sedatives in a hospital support team and in hospice. Palliat Med 1997; 11: 140-144.
17. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001; 21(6): 467-472.